A drug discovery venture pioneering novel cancer therapies through innovative technologies.

Challenging unmet medical needs with new drug development

Our vision

Revolutionizing healthcare, treatment methodologies, and economic rationality through groundbreaking research and exploratory studies, transcending conventional wisdom to embark on a new era.

Mission statement

Creating or discovering innovative anti-cancer drugs through industry-academia collaboration, ensuring a high quality of life (QOL) for patients post-treatment, free from anxiety. We aim to contribute to a society that can adapt to societal changes by improving healthy life expectancy.

Value

  • Approaching all cancer treatments with a fresh perspective, unconstrained by existing concepts.
  • Challenge areas where treatment is prolonged, rather than solely focusing on market size.
  • Contributing to reducing the burden on patients through cost-effective therapies.
  • Leaping to a new dimension in cancer treatment with novel ideas and perspectives.

News

Message

Founder's Message

Chihaya Kakinuma,

Representative Director,HOIST Corp.
Read Here →

Founder's Message

Former Professor Kazutake Tsujikawa,
Graduate School of Pharmaceutical Sciences, The University of Osaka
Read Here →

Access

Headquarters

Headquarters: NLC Shin-Osaka Earth Bldg. 5F #511, 5-1-3, Miyahara, Yodogawa-ku, Osaka-shi, Osaka, 532-0003, JAPAN
Tel: +81-6-7777-2580
Partnership

Wakayama Medical University Collaborative Research Laboratory

811-1 Kimiidera, Wakayama, Wakayama 641-8509, Japan
Center for Next-Generation Medicine Research, 401, Kimiidera Campus, Wakayama Medical University
Business
Pipeline
Technical info
Partnership
Privacy Policy
Policy on Anti-Social Forces
Basic Policy on Bribery